Takara Bio Inc. reported unaudited consolidated earnings results for the year ended March 31, 2021. For the year, the company reported net sales of JPY 46,086 million against JPY 34,565 million a year ago. Operating profit was JPY 13,952 million against JPY 6,274 million a year ago. Net income attributable to owners of parent was JPY 9,547 million or JPY 79.29 per share against JPY 3,819 million or JPY 31.72 per share a year ago.